NeuroSense Therapeutics Ltd.
NRSN
$1.14
-$0.0301-2.57%
NASDAQ
06/30/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | ||
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -44.87% | 27.95% | -82.96% | -43.64% | |
Total Receivables | 125.27% | -1.20% | -13.36% | -27.29% | |
Inventory | -- | -- | -- | -- | |
Prepaid Expenses | -- | 24.29% | -- | -- | |
Finance Division Loans and Leases Current | -- | -- | -- | -- | |
Total Finance Division Other Current Assets | -- | -- | -- | -- | |
Other Current Assets | 22.86% | -12.50% | -7.89% | 60.87% | |
Total Current Assets | -3.89% | 50.96% | -78.59% | -42.59% | |
|
|||||
Total Current Assets | -3.89% | 50.96% | -78.59% | -42.59% | |
Net Property, Plant & Equipment | -47.50% | -39.27% | -29.58% | -14.47% | |
Long-term Investments | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | |
Total Other Intangibles | -- | -- | -- | -- | |
Finance Div Loans & Leases LT | -- | -- | -- | -- | |
Total Finance Div Other LT Assets | -- | -- | -- | -- | |
Total Other Assets | 4.55% | 4.55% | -4.35% | -38.24% | |
Total Assets | -8.53% | 43.64% | -76.60% | -41.65% | |
|
|||||
Total Accounts Payable | -26.30% | -20.49% | 36.06% | 343.20% | |
Total Accrued Expenses | -- | -60.69% | -- | -- | |
Short-term Debt | -- | -- | -- | -- | |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
Finance Division Debt Current | -- | 5.80% | -- | -- | |
Total Finance Division Other Current Liabilities | -45.19% | -- | 5.74% | -- | |
Total Other Current Liabilities | -45.19% | -- | 5.74% | -- | |
Total Current Liabilities | -37.20% | -42.41% | 16.74% | 246.36% | |
|
|||||
Total Current Liabilities | -37.20% | -42.41% | 16.74% | 246.36% | |
Long-Term Debt | -- | -- | -- | -- | |
Short-term Debt | -- | -- | -- | -- | |
Capital Leases | -- | -- | -65.38% | -51.45% | |
Finance Division Debt Non Current | -- | -- | -- | -- | |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
Total Other Liabilities | -- | -- | -- | 572.25% | |
Total Liabilities | -37.84% | -59.71% | -62.35% | 303.32% | |
|
|||||
Common Stock & APIC | 33.15% | 61.08% | 8.20% | 13.49% | |
Retained Earnings | -27.75% | -40.35% | -8.30% | -65.09% | |
Treasury Stock & Other | -- | -- | -- | -- | |
Total Common Equity | 69.52% | 246.84% | -10.23% | -102.50% | |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | |
Preferred Stock Non Redeemable | -- | -- | -- | -- | |
Preferred Stock Convertible | -- | -- | -- | -- | |
Preferred Stock, Others | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | |
|
|||||
Total Common Equity | 69.52% | 246.84% | -10.23% | -102.50% | |
Total Preferred Equity | -- | -- | -- | -- | |
Total Minority Interest | -- | -- | -- | -- | |
Total Equity | 69.52% | 246.84% | -10.23% | -102.50% | |
|